ADRX

12.8559.22%
RF

Ryan Fisk

CFO & Chief Business Officer

Mr. Ryan Fisk, M.B.A., is Chief Financial Officer & Chief Business Officer of ADARx Pharmaceuticals, Inc. from March 24, 2026. In this role, he is responsible for leading finance, strategy, corporate development and investor relations for the company. He joined ADARx from Goldman Sachs where he served as Managing Director in the Healthcare Investment Banking Group focused on the biotech industry and brings more than 20 years of experience partnering with executive teams and boards of innovative growth companies to guide and execute strategic and financial transactions. He began his investment banking career in 2004 and has been focused exclusively on the biotech industry since 2012. Over his career, he has developed deep strategic and financial expertise through extensive experience advising clients ranging from private and small-cap biotechnology companies to large-cap pharmaceutical organizations on their holistic growth strategies and capital markets, M&A and partnership transactions. Mr. Fisk has advised on biotech financing transactions totaling over 60 billion in value and biotech M&A and partnership transactions totaling over 75 billion in value. Prior to Goldman Sachs, he held senior leadership roles in the Healthcare Investment Banking Groups at Bank of America Merrill Lynch and Credit Suisse. He earned an M.B.A. from Columbia University and a B.A. in Economics and Political Science from the University of California, Los Angeles.

Positions